Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

Podobne knjige/članki

• Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies
  od: Steele, Anna M., et al.
  Izdano: (2013)
• South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European people
  od: Misra, Shivani, et al.
  Izdano: (2016)
• Response to Comment on: Chakera et al. Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia due to a Glucokinase Mutation Requires Treatment. Diabetes Care 2012;35:1832–1834
  od: Chakera, Ali J., et al.
  Izdano: (2013)
• Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia Due to a Glucokinase Mutation Requires Treatment
  od: Chakera, Ali J., et al.
  Izdano: (2012)
• Assessment of the HNF1B Score as a Tool to Select Patients for HNF1B Genetic Testing
  od: Clissold, Rhian, et al.
  Izdano: (2015)